![Analysis: is it wise for England to mix and match Covid vaccines? | Vaccines and immunisation | The Guardian Analysis: is it wise for England to mix and match Covid vaccines? | Vaccines and immunisation | The Guardian](https://i.guim.co.uk/img/media/0d91bcf45625fff995dd0427f45f7d8af6d0a9f9/0_232_3500_2100/master/3500.jpg?width=1200&height=1200&quality=85&auto=format&fit=crop&s=2f415aacacebcb96e0ef6e03fa553fda)
Analysis: is it wise for England to mix and match Covid vaccines? | Vaccines and immunisation | The Guardian
![COVID-19: New hope rides on protein-based vaccines | Science | In-depth reporting on science and technology | DW | 20.12.2021 COVID-19: New hope rides on protein-based vaccines | Science | In-depth reporting on science and technology | DW | 20.12.2021](https://static.dw.com/image/59868803_401.jpg)
COVID-19: New hope rides on protein-based vaccines | Science | In-depth reporting on science and technology | DW | 20.12.2021
![COVID-19 Booster Vaccine: What Is It & When Can I Get It? | BetterMed Urgent Care: Greater Richmond, Fredericksburg & North Carolina COVID-19 Booster Vaccine: What Is It & When Can I Get It? | BetterMed Urgent Care: Greater Richmond, Fredericksburg & North Carolina](https://www.bettermedcare.com/wp-content/uploads/2021/11/COVID-19-Booster-Vaccine-1.png)
COVID-19 Booster Vaccine: What Is It & When Can I Get It? | BetterMed Urgent Care: Greater Richmond, Fredericksburg & North Carolina
![Stream PREMIERE: DJ Tribe - Impfung (Hackfreed Remix) [Vorwärts Musik] by DJ Mag ES | Listen online for free on SoundCloud Stream PREMIERE: DJ Tribe - Impfung (Hackfreed Remix) [Vorwärts Musik] by DJ Mag ES | Listen online for free on SoundCloud](https://i1.sndcdn.com/artworks-m1mSB82iDEVXH9Oy-G7qXRA-t500x500.jpg)
Stream PREMIERE: DJ Tribe - Impfung (Hackfreed Remix) [Vorwärts Musik] by DJ Mag ES | Listen online for free on SoundCloud
![COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1619703711/GettyImages-1293456793.jpg/GettyImages-1293456793.jpg?VersionId=WB8tj9FiBVgpCnJxtaqj0TT3Gnf4tWIM)
COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma
![COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fbb0b4c9-da65-4ed2-9df0-09e56d5ef8f3/gr1_lrg.jpg)
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases
![Chinese mRNA booster fights Omicron 4 times better than inactivated Covid-19 vaccines, researchers say | South China Morning Post Chinese mRNA booster fights Omicron 4 times better than inactivated Covid-19 vaccines, researchers say | South China Morning Post](https://cdn.i-scmp.com/sites/default/files/styles/wide_landscape/public/d8/video/thumbnail/2022/05/20/Thumbnail%20-%20Clean_0.jpg?itok=dh2-NgFS)
Chinese mRNA booster fights Omicron 4 times better than inactivated Covid-19 vaccines, researchers say | South China Morning Post
![Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial - Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial -](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4f63598f-c60b-45d0-a83a-80252b2ff690/gr1.gif)
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial -
![Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens | Nature Communications Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-32321-0/MediaObjects/41467_2022_32321_Fig1_HTML.png)